MFDS — authorised 6 August 2014
- Marketing authorisation holder: THE MEDICINES CO
- Status: likely_approved
MFDS authorised Orbactiv on 6 August 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 6 August 2014.
THE MEDICINES CO holds the South Korean marketing authorisation.